Epstein Secrets

op) Key Research: MS initiates SRCL (ew), HSBC upgrades global financials & downgrades energy / industrials Key Research: Macquarie upgrades MBFI, Wells initiates INCY (mp) & YMI/SPR (op's), MS downgrades CVC Key Research: Barclays upgrades KWK & DNR, KBW downgrades WDR, HSBC upgrades SYMN Key Rese

(set aside EFTA00435925 20% for conservation) U.K. manufacturing production unexpectedly stalled in Feb (unchanged from Jan vs estimate 40.6%) Marks & Spencer gains the most in six months as sales fall less than estimated (trading 45.47%) Novartis asks EU regulators to approve the Prexige pain pill that w

••• Opco downgrades ANN, HSBC upgrades C, ISI upgrades EGN (strong buy), MS cuts RDC ••• PacCrest upgrades INTC, RBC upgrades KND, GS upgrades JBLU, Wells upgrades LII Europe Key Research: • Banca IMI upgrades TFI IM, Banco Santander upgrades CABK SM, Barcap upgrades GRT SJ • Berenberg downgrades OSR

f Fraser Stake (Sunday Times) (trading -0.92%) • Leg Immobilien: €300 million convertible bond launch (pricing expected today) (trading -0.95%) • Marks & Spencer may miss sales targets laid out 2yrs ago says Sunday Times (trading -1.1%) • Germany Feb industry output expands more than forecast (+0.4% m/m vs e

CS resumes CYH & THC (op's), GS downgrades Russian Oil sector Key Research: GS upgrades KBR (conviction buy) & initiates MSI (buy) & downgrades IM, Wells upgrades CR20, Wunderlich downgrades RIMM Key Research: Moke initiates LOGM & ZIXI (op's), MS upgrades CRM, Opco initiates AIS (op), Bofa resumes TH

gn to "explore other opportunities") Valeant (VRX) agrees to buy AB Sanitas for 0314 million to add dermatology drugs in Eastern & Central Europe Marks & Spencer reports broadly inline with expectations but sounds cautious tone on outlook (trading -2.0%) U.K. budget deficit widens to $16.1B as tax receipts f